Middle East Pharmaceutical Industries Company SJSC 4016.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
62.05
-2.97%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Middle East Pharmaceutical Industries Company SJSC
Its shares trade on Tadawul under the ticker 4016.SR. It has been listed since 27 February 2024. In the fiscal year to 31 December 2025, it reported revenue of SAR 460.5m and net income of SAR 97.0m. At that date it held total assets of SAR 599.5m and shareholders' equity of SAR 416.2m.
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 27 Feb 2024
- Employees
- 335
- Website
- avalonpharmaceutical.com ↗
Leadership
Pay as last reported
- Mr. Ahmad Shaher Ahmad Al-TabbaaNon-Independent Non-Executive Chairman of the Board, since 2022
- Mr. Mohammed Maher Mohammedlotfi Al-GhannamChief Executive Officer, Managing Director, Non-Independent Executive Director, since 2018
- Mr. Hisham Mohammed AttarIndependent Non-Executive Deputy Chairman of the Board, since 2022
- Mr. Moazam A. ShahChief Financial Officer
- Mr. Rasheed Abdulaziz Mohammed Al-RasheedChief Operations Officer
- Mr. Bander Mohammed Al-rasheedExecutive Vice President - Finance and Corporate Development
- Mr. Hamoud Desan Al-AnaziChief Administrative Officer
- Mr. Fayez Basem Fayez AwadaChief Marketing Officer
- Mr. Mohammed Marzouq Al-MoaiteqManager of Compliance
- Mr. Wael Madbouly HassaneinManager - Internal Audit
- Mr. Mohammed Ibrahim SalamaChief Commercial Officer
- Mr. Ammar Mamoun Abdel Wahab AlhajjehSecretary of the Board of Directors
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company manufactures generic medicines and pharmaceuticals for human use.
- It produces disinfectants and sterilizers for medical devices and products.
- The firm develops cosmetics alongside its core pharmaceutical preparations.
Weaknesses
- The company employs only 335 full-time staff members globally.
- It operates from a single headquarters in Riyadh, Saudi Arabia.
- The business relies on a narrow range of manufactured products.
Opportunities
- The firm can expand its market for medical device sterilizers.
- Growing demand for generic medicines offers significant revenue potential.
- Developing new cosmetic lines could diversify its product portfolio.
Threats
- Intense competition in the Saudi Arabian pharmaceutical market exists.
- Regulatory changes in Saudi Arabia may impact manufacturing processes.
- Economic fluctuations in the region could affect consumer spending.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.